L009 Changes in cardiac transcriptome induced by altered corticosteroid receptor signaling in the heart - 17/04/09
Résumé |
Aldosterone plays a major role in the regulation of extracellular volume and blood pressure, through its renal action via the mineralocorticoid receptor (MR). The extra-renal roles of aldosterone/MR in non-epithelial cells (neurones, cardiomyocytes, vessels, adipocytes…) are now intensively investigated. Animal models (aldo/DOCA-salt) and clinical trials (RALES, EPHESUS) evidenced a major pathophysiological contribution of aldosterone/ MR in the cardiovascular system. To evaluate MR cardiac signaling, we analyzed the transcriptomic profile of 2 transgenic mouse models with conditional and inducible overexpression of the MR or of the glucocorticoid receptor (GR) in cardiomyocytes (MHCMR and MHC-GR). Using dedicated cardiochips, we identified 520 cardiac genes that are differentially expressed between control and MHC-MR mice (250 up, 270 down-regulated), and 1232 genes differentially expressed between control and MHC-GR mice (728 up, 504 down-regulated). Some of these genes were validated by real-time PCR, such as Periostin [MHC-MR vs control 10.56±2.2, p=0.02 ; MHC-GR vs control 4.36±1.72, NS], Troponin T3 [MHC-MR vs control 41.66±9.23, p=0.048 ; MHC-GR vs control 1.78±0.41, NS], Fkbp5 [MHC-MR vs control 34.51±6.16, p=0.01 ; MHC-GR vs control 3.33±0.59, p=0.006].
We have also compared the effects of aldosterone in the presence or not of different MR/GR antagonists on gene expression in a cardiomyocytes cell line (H9C2 cells) stably expressing the MR, in order to analyze hormone and antagonist specificity.
Importantly, some of the MR-specific genes encode for secreted proteins that may represent novel markers of MR activation in circulating blood, including in human pathology.
Le texte complet de cet article est disponible en PDF.Plan
Vol 102 - N° S1
P. S120-S121 - mars 2009 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.